3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Head & Neck
1
Endocrine
1
Conditions
Breast Neoplasms
3
Pancreatic Neoplasms
2
Melanoma
2
Thyroid Neoplasms
1
Thyroid Cancer, Papillary
1
Prostatic Neoplasms
1
Neoplastic Cells, Circulating
1
Myelodysplastic Syndromes
1
Medulloblastoma
1
Leukemia, Myeloid, Acute
1
Head and Neck Neoplasms
1
Colorectal Neoplasms
1
Carcinoma, Non-Small-Cell Lung
1
Advanced Pancreatic Cancer
1
Interventions
Iodine-131
5
dabrafenib
4
Vemurafenib
4
Magnetic Resonance Spectroscopy
4
trametinib
3
lenvatinib
3
Transurethral Resection of Prostate
3
Thyrotropin Alfa
3
Thyroidectomy
3
selpercatinib
2
cobimetinib
2
X-Rays
2
Thyroid (USP)
2
Surgical Procedures, Operative
2
Sunitinib
2
Specimen Handling
2
Radiofrequency Ablation
2
Interviews as Topic
2
vandetanib
1
tremelimumab
1
spartalizumab
1
pembrolizumab
1
pazopanib
1
durvalumab
1
delta 24-sterol reductase
1
copanlisib
1
cabozantinib
1
Whole Body Imaging
1
Thyrotropin
1
Thalidomide
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Thyroid Cancer, Papillary
×
Digoxin
×
Clear all
NCT05507775
2024-04-11
DIGUP-TC
Radboud University Medical Center
Phase NA
Completed
8 enrolled